137 related articles for article (PubMed ID: 6219576)
1. Treatment of serious infections with moxalactam.
Ribner BS; Raeder R; Becker TM; Freimer EH
Am J Med; 1983 Mar; 74(3):396-400. PubMed ID: 6219576
[TBL] [Abstract][Full Text] [Related]
2. Moxalactam therapy for a wide spectrum of bacterial infections in adults.
Tofte RW; Rotschafer J; Solliday J; Crossley KB
Antimicrob Agents Chemother; 1981 May; 19(5):740-4. PubMed ID: 6457555
[TBL] [Abstract][Full Text] [Related]
3. Treatment of intraabdominal infection with moxalactam.
Murphy TF; Barza M
Rev Infect Dis; 1982; 4 Suppl():S670-5. PubMed ID: 6218581
[TBL] [Abstract][Full Text] [Related]
4. Moxalactam in serious infections: clinical, bacteriologic, and pharmacokinetic studies.
Giamarellou H; Tsagarakis J; Daikos GK
Rev Infect Dis; 1982; 4 Suppl():S629-38. PubMed ID: 6218576
[TBL] [Abstract][Full Text] [Related]
5. Clinical efficacy of moxalactam with emphasis on infections due to multidrug-resistant organisms in patients with renal insufficiency.
Trager GM; Panwalker AP; Malow JB; Porembski PE; Ramirez CA; Zar FA
Chemotherapy; 1981; 27(4):287-95. PubMed ID: 6454542
[TBL] [Abstract][Full Text] [Related]
6. Moxalactam therapy for bacterial infections.
Winston DJ; Busuttil RW; Kurtz TO; Young LS
Arch Intern Med; 1981 Nov; 141(12):1607-12. PubMed ID: 6458253
[TBL] [Abstract][Full Text] [Related]
7. Moxalactam therapy of bacterial meningitis in adults.
Uwaydah M; Tannir N; Kantarjian H; Osseiran M; Bal'a F
Antimicrob Agents Chemother; 1983 Feb; 23(2):289-92. PubMed ID: 6220673
[TBL] [Abstract][Full Text] [Related]
8. Moxalactam in the treatment of pediatric infections.
Yogev R; Schreiber M; Gardner S; Shulman ST
Am J Dis Child; 1982 Sep; 136(9):836-9. PubMed ID: 6214182
[TBL] [Abstract][Full Text] [Related]
9. Therapy of lower respiratory tract infections with moxalactam.
Lentino JR; Rytel MW; Moore E
Antimicrob Agents Chemother; 1981 May; 19(5):801-6. PubMed ID: 6457557
[TBL] [Abstract][Full Text] [Related]
10. Clinical evaluation of moxalactam: evidence of decreased efficacy in gram-positive aerobic infections.
Salzer W; Pegram PS; McCall CE
Antimicrob Agents Chemother; 1983 Apr; 23(4):565-70. PubMed ID: 6222696
[TBL] [Abstract][Full Text] [Related]
11. Enterococcal superinfection and colonization after therapy with moxalactam, a new broad-spectrum antibiotic.
Yu VL
Ann Intern Med; 1981 Jun; 94(6):784-5. PubMed ID: 6453542
[No Abstract] [Full Text] [Related]
12. New drug evaluations: moxalactam (Moxam, Eli Lilly).
Polk RE
Drug Intell Clin Pharm; 1982 Feb; 16(2):104-12. PubMed ID: 6210519
[TBL] [Abstract][Full Text] [Related]
13. Emergence of resistance to beta-lactam and aminoglycoside antibiotics during moxalactam therapy of Pseudomonas aeruginosa infections.
Preheim LC; Penn RG; Sanders CC; Goering RV; Giger DK
Antimicrob Agents Chemother; 1982 Dec; 22(6):1037-41. PubMed ID: 6218778
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics and clinical efficacy of moxalactam in biliary tract infections.
Mueller O; Fabricius K; Krueger E; Rueckert U
Rev Infect Dis; 1982; 4 Suppl():S688-91. PubMed ID: 6218584
[TBL] [Abstract][Full Text] [Related]
15. Moxalactam therapy of infections caused by cephalothin-resistant bacteria: influence of serum inhibitory activity on clinical response and acquisition of antibiotic resistance during therapy.
Platt R; Ehrlich SL; Afarian J; O'Brien TF; Pennington JE; Kass EH
Antimicrob Agents Chemother; 1981 Sep; 20(3):351-5. PubMed ID: 6458233
[TBL] [Abstract][Full Text] [Related]
16. Successful moxalactam therapy for gram-negative bacillary meningitis in neonates.
Ramos OM; Kaplan SL; Mason EO; Denson S; Pickering LK
South Med J; 1982 May; 75(5):632-3. PubMed ID: 6210970
[TBL] [Abstract][Full Text] [Related]
17. Clinical experience with Moxalactam in the treatment of pseudomonal and nonpseudomonal infections.
Murphy TF; Barza M
Antimicrob Agents Chemother; 1982 Apr; 21(4):568-74. PubMed ID: 6211137
[TBL] [Abstract][Full Text] [Related]
18. Moxalactam in the treatment of intraabdominal sepsis and other surgical infections.
Busuttil RW; McGrattan MA; Winston DJ
Rev Infect Dis; 1982; 4 Suppl():S676-82. PubMed ID: 6218582
[TBL] [Abstract][Full Text] [Related]
19. Clinical evaluation of moxalactam.
Mathisen GE; Meyer RD; Thompson JM; Finegold SM
Antimicrob Agents Chemother; 1982 May; 21(5):780-6. PubMed ID: 6213198
[TBL] [Abstract][Full Text] [Related]
20. In vitro antibacterial activity of moxalactam, a new broad-spectrum semisynthetic antibiotic.
Skalova R; Hajsig D; Muic V; Kapun D
Infection; 1980; 8 Suppl 3():S 330-3. PubMed ID: 6447672
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
